Embody vs Sprout Health: Low Price vs Fast Approval Compared
Embody vs Sprout Health is a choice between a low entry price and a fast, outcome-focused pitch. Early verdict: choose Embody if lowest ongoing cash price and 1–2 day shipping matter most; choose Sprout Health if you want a fast approval process and an introductory discount.
Start with Embody at $69/month
Price and ongoing cost: cheap ongoing vs discounted start
Embody lists compounded semaglutide at $69/month, cut from $299, and compounded tirzepatide at $119/month. Sprout Health advertises $50 off the first month, bringing the initial cost to $199, with ongoing pricing of $249/month. That makes Embody the lower ongoing cost while Sprout Health focuses on a lower first-month entry price for new patients.
See Embody pricing and details
Approval speed, shipping, and onboarding
Both platforms use online clinician review. Sprout Health emphasizes lightning-quick approval and a low-friction onboarding designed for fast entry. Embody promises medication shipped free in 1–2 days after clinician approval, highlighting fast delivery once approved. Choose Sprout Health for speed through the approval step and Embody for fast post-approval delivery.
Medication type and regulatory note
Both providers prescribe compounded semaglutide via telehealth. Embody’s materials state its compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Sprout Health’s captured note says compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both presentations preserve the same regulatory limitation.
Features and program focus
Embody runs a lean program focused on low monthly pricing, with no monthly membership, cancel anytime policies, and fewer premium add-ons. It highlights 24/7 support access for dosing and side-effect questions but notes fewer coaching and monitoring tools than higher-priced platforms. Sprout Health promotes clear outcome framing, citing a 10 to 26 percent body weight reduction over 12 months as an outcome frame and positions itself as a fast, hassle-free entry with a promotional first-month discount. Sprout Health does not publish a formal outcome guarantee.
| Criteria | Embody | Sprout Health |
|---|---|---|
| Starting price | $69/month semaglutide (was $299) | $50 off first month, initial $199 |
| Ongoing price | $69/month semaglutide; $119 tirzepatide | $249/month ongoing |
| Approval speed | Licensed provider review handled online; fast shipping after approval | Lightning-quick approval process |
| Shipping | Free shipping; arrives in 1–2 days after approval | Shipped to your door following approval; speed emphasized but shipping terms not captured |
| Medication type | Compounded semaglutide and tirzepatide; compounded meds not FDA-approved finished products | Compounded semaglutide when offered; compounded meds not FDA-approved |
| Best for | Cost-driven patients wanting straightforward GLP-1 program | Patients wanting fast, low-friction entry and clear outcome framing |
Direct comparison of top differences
1. Ongoing cost vs introductory discount
Embody emphasizes an ongoing low cash price of $69/month for compounded semaglutide and $119/month for compounded tirzepatide. Sprout Health emphasizes a $50 first-month discount to $199 with a $249/month ongoing price. The trade-off is Embody’s lower ongoing cost versus Sprout Health’s lower first-month outlay.
2. Speed of approval versus speed of delivery
Sprout Health highlights lightning-quick approval as a primary feature. Embody highlights 1–2 day free shipping after clinician approval. If the bottleneck you care about is getting a prescription cleared quickly, Sprout Health markets faster approval. If you care about rapid delivery after approval, Embody documents a 1–2 day shipping commitment.
3. Program features and monitoring
Embody describes a no-frills, price-first model with fewer premium coaching or advanced monitoring tools and a cancel anytime policy. Sprout Health frames outcomes and a fast onboarding experience but does not advertise a formal outcome guarantee in the captured evidence.
Get Sprout Health first-month offer
How to choose between Embody vs Sprout Health
Both platforms are licensed telehealth providers prescribing compounded semaglutide after clinician review and both note compounded medications are not FDA-approved finished products. Your decision should rest on cost sensitivity and process preferences.
Start Embody for the lowest ongoing price
- Choose Embody if you prioritize the lowest ongoing cash price, a $69/month semaglutide option, and free 1–2 day shipping after approval.
- Choose Sprout Health if you prioritize lightning-quick approval and a first-month discount that brings the start cost to $199, with an ongoing price of $249/month.
Start Sprout Health with the $50 first-month discount
Final note: Embody vs Sprout Health compares a lowest-cost, fast-delivery option against a fast-approval, outcome-framed option. Review the exact pricing, shipping, and clinician requirements on each provider’s site before deciding.